Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991;283(5):333-6.
doi: 10.1007/BF00376623.

Dithranol-induced down-regulation of 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] receptors in a human epidermal cell line

Affiliations

Dithranol-induced down-regulation of 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] receptors in a human epidermal cell line

L Kemény et al. Arch Dermatol Res. 1991.

Abstract

The effects of dithranol and its therapeutically inactive oxidation product, danthrone, on 12(S)-HETE binding to the human epidermal cell line SCL-II were studied. Dithranol (0.25-1 microgram/ml), in contrast to danthrone, induced a substantial decrease in 12(S)-HETE binding in a dose-dependent manner. The inhibition occurred after a latency period of 6 h, reached its maximum at 18-24 h and slowly declined thereafter. At a concentration of 1 microgram/ml, the drug led to an approximately 50% decrease in the number of specific high-affinity 12(S)-HEFE receptors (Bmax), whereas receptor affinity (Kd) showed no change. The down-regulation of 12(S)-HETE receptors on epidermal cells by dithranol may contribute to its antipsoriatic action.

PubMed Disclaimer

Similar articles

References

    1. Skin Pharmacol. 1990;3(1):1-20 - PubMed
    1. Arch Dermatol Res. 1988;280 Suppl:S33-41 - PubMed
    1. Br J Dermatol. 1983 Mar;108(3):295-9 - PubMed
    1. Arch Dermatol Res. 1986;278(6):449-53 - PubMed
    1. J Invest Dermatol. 1985 Jun;84(6):537-41 - PubMed

Publication types

MeSH terms

LinkOut - more resources